Home > Chemicals & Materials > Advanced Materials > Electrophoresis Reagents Market
Electrophoresis Reagents Market size was valued at USD 2.5 billion in 2022 and is estimated to register 5.1% CAGR between 2023 and 2032. Electrophoresis reagents are widely used in the biotechnology and pharmaceutical industries owing to the increasing demand for novel therapeutics, personalized medicine, and diagnostics in these sectors. Electrophoresis is utilized in clinical diagnostics for the separation & analysis of proteins and other biomarkers. The need for accurate & reliable diagnosis of diseases and disorders is fueling the demand for electrophoresis reagents in clinical laboratories and diagnostic centers. Electrophoresis reagents are also witnessing rising adoption in forensic applications including DNA profiling, crime scene analysis, and forensic identification.
The agriculture and food industries employ electrophoresis techniques to analyze genetic markers, DNA fingerprinting, and the quality of food products. The need for improved crop breeding, food safety testing, and genetic traceability is influencing the demand for electrophoresis reagents in this sector.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Electrophoresis Reagents Market Size in 2022: | USD 2.5 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 5.10% |
2032 Value Projection: | USD 4.2 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 175 |
Tables, Charts & Figures: | 194 |
Segments covered: | Type, Technique, End Use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|
The high cost of electrophoresis reagents poses a significant challenge, particularly for research laboratories and academic institutions with limited budgets. This high cost can limit their accessibility and impede research activities. Variability in reagents and experimental conditions can affect the accuracy & reliability of results, affecting data interpretation and comparison. Alternative separation and analysis technologies, such as mass spectrometry and High-performance Liquid Chromatography (HPLC), offer advantages in terms of sensitivity, resolution, and automation, restricting the electrophoresis reagents market. Thus, the high cost & low availability of electrophoresis reagents and the presence of competing technologies may limit product adoption, further hampering market growth.
The pandemic disrupted the global production & distribution of electrophoresis reagents. Reduced manufacturing activities, transportation delays, and shortages of raw materials disrupted the overall supply chain, affecting the availability of reagents. Governments worldwide imposed lockdown measures and safety protocols, forcing many research laboratories and academic institutions to temporarily halt or reduce operations. This delayed research activities and projects that relied on electrophoresis techniques and reagents, reducing their demand during this period. On the other hand, clinical diagnostics, particularly COVID-19 testing, using these techniques witnessed a surging demand as they were employed for analyzing proteins and biomarkers relevant to COVID-19 diagnosis.
Electrophoresis reagents specifically designed for protein analysis, such as Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Western blotting, are in high demand owing to the increasing focus on understanding protein structure, function, and interactions. Automated electrophoresis systems integrated with advanced reagents and software are being increasingly adopted in research laboratories and diagnostic facilities as they offer improved efficiency and reduced human errors.
The need for high-throughput analysis, standardization, and reproducibility of results is propelling their demand. Capillary Electrophoresis (CE) is gaining popularity as an alternative to traditional gel-based electrophoresis methods owing to its advantages such as higher resolution, faster separations, and reduced sample & reagent consumption. The surging demand for electrophoresis reagents specifically formulated for capillary electrophoresis is attributed to techniques in genomics, proteomics, and clinical diagnostics.
Based on type, the electrophoresis reagents market is segmented into gels, buffers, stains & dyes, and markers & ladders. The gels segment crossed USD 1.3 billion in 2022. Gel electrophoresis reagents are essential for DNA sequencing, genotyping, fragment analysis, and RNA expression profiling. These reagents are widely used in research activities related to genetics, genomics, and molecular biology. Gel electrophoresis reagents are also utilized in protein analysis for protein separation, identification, and characterization. Other applications including proteomics research, drug discovery, and diagnostics are contributing to the rising demand for gel electrophoresis reagents. The specific factors may vary depending on research trends, industry requirements, and advancements in electrophoresis techniques.
Based on technique, the electrophoresis reagents market is bifurcated into gel electrophoresis and capillary electrophoresis. The gel electrophoresis segment accounted for approximately 60% of the market share in 2022 and is expected to grow at a lucrative pace through 2032. Gel electrophoresis reagents are used in protein analysis as well as in proteomics research, drug discovery, and diagnostics. Capillary electrophoresis reagents are crucial for DNA sequencing applications including Sanger sequencing and fragment analysis, augmenting their demand in genetic research, clinical diagnostics, and forensic analysis. Capillary electrophoresis reagents are also witnessing high adoption in proteomics research and biopharmaceutical analysis.
Based on end use, the electrophoresis reagents market is divided into life sciences & biotechnology, clinical diagnostics, pharmaceutical & biopharmaceutical, and academic & research institutions. The life sciences & biotechnology segment held a dominant market share in 2022 and is predicted to observe about 6.6% CAGR through 2032. The biopharmaceutical & pharmaceutical industry segment is a major consumer of electrophoresis reagents as they are used in techniques such as DNA sequencing, genotyping, protein analysis, and quality control of biopharmaceutical products. The need for accurate & reliable analysis of biomolecules fuels the demand for electrophoresis reagents in this industry. Academic institutions, research laboratories, and universities use electrophoresis reagents for various applications, thereby augmenting market statistics.
U.S. electrophoresis reagents market dominated the North American region with a major revenue of USD 1.6 billion in 2022 and is anticipated to expand at a significant pace from 2023 to 2032. North America is a hub for research & development in the fields of biotechnology, pharmaceuticals, and life sciences. Electrophoresis techniques & reagents offer advanced tools that support cutting-edge research projects, such as genomics, proteomics, and drug discovery, thereby increasing their demand in the healthcare sector in North America for clinical diagnostics. North America has a strong biopharmaceutical industry, which relies on electrophoresis reagents for quality control, process development, and product characterization.
Some major players operating in the electrophoresis reagents market are:
These players focus on strategic partnerships, new product launches, and commercialization efforts for market expansion. They heavily invest in research to introduce innovative products and garner maximum market revenue.
Click here to Buy Section of this Report
Market, By Type
Market, By Technique
Market, By End Use
The above information is provided for the following regions and countries: